Micropulse treatment of vitreoretinal pathologies: retrospective and prospective study to collect patient data after subthreshold micropulse treatment
Not Applicable
Recruiting
- Conditions
- H35.3Degeneration of macula and posterior pole
- Registration Number
- DRKS00023869
- Lead Sponsor
- Augenklinik SulzbachKnappschaftsklinikum Saar/Sulzbach
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
untreated patients with a diagnosis of intermediate AMD without the presence of reticular pseudodrusen
Exclusion Criteria
- reticular pseudodrusen
- severe systematic diseases
- turbid refracting media
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoints are: <br>1) progression to geographic atrophy (GA) by fundus autofluorescence or SD-OCT.<br>2) Incidence of CNV (choroidal neovascularization).
- Secondary Outcome Measures
Name Time Method Secondary endpoints: <br>1) BCVA<br>2) drusen volume